Aspergillus niger (IAFB 2301) was employed for bioconversions of 2-phenylethanol as an immobilized or free mycelium and also as a spore suspension. Experiments were conducted on laboratory and half-preparative scale (bioreactor New Brunswick Scientific, BioFlo Model C32). Thus, A. niger applied as free mycelium, depending on the outcome, supported formation of the mixture of 4-hydroxyphenylacetic acid and hydroxytyrosol (final concentration of 13.8 mg/L and 3.7% efficiency) or 4-hydroxyphenylacetic acid, as single product (final concentration of 140 mg/L and 18% efficiency). In case of scaling experiments conducted with flow and batch reactors, accordingly, the following results were achieved: 1. mixture of antioxidants 4-hydroxyphenylacetic acid and hydroxytyrosol formed with final concentration of 76 mg/L and 10% efficiency (simplified flow system and immobilized mycelium); 2. (S)-1-phenylethane-1,2-diol synthesized with a final concentration of 447 mg/L and 65% (1.3 L batch reactor).
Three fungal strains were employed for the stereoselective oxidation of the cheap and commercially available substrate 2-phenylethanol, which resulted in chiral building blocks being received. The whole-cell biocatalysts were as follows: Beauveria bassiana DSM 1344, Beauveria brongniartii DSM 6651, and Rhizopus arrhizus DSM 1185. The main product of Beauveria bassiana bioconversion was 1-phenylethane-1,2-diol, obtained, depending on the form of the biocatalyst, as an R-enantiomer (e.g., 99.9%) with fresh biomass application or as a racemic mixture in cases of immobilization in agar-agar. The best and most innovative results for the synthesis of the R-enantiomer of diol were received under precisely defined conditions as a result of a scaling study conducted on an automatic batch reactor. This is a pioneering result, since, in previous studies, fresh mycelium of Aspergillus niger resulted in this product being received as the (S) enantiomer. Also, the use of Rhizopus arrhizus DSM 1185 (immobilized in polyurethane foams) presented important results, as the bioconversion of phenyl ethanol led, indeed, to the racemic mixture of 1-phenylethane-1,2-diol but was accompanied by a noticeable tyrosol synthesis, which had not been reported previously.
Three fungal strains were employed for stereoselective oxidation of the cheap and commercially available substrate 2-phenylethanol, what resulted in chiral building blocks receiving. Whole-cells biocatalysts were as follows: Beauveria bassiana DSM 1344, Beauveria brongniartii DSM 6651 and Rhizopus arrhizus DSM 1185. The main product of Beauveria bassiana bioconversion, was 1-phenylethane-1,2-diol obtained, depending on the form of the biocatalyst, as a R-enantiomer (e.g. 99.9%), with fresh biomass application or as racemic mixture in case of immobilization in agar- agar. The very best and pioneer results for the synthesis of R-enantiomer of diol were received under precisely defined conditions, and as a results of scaling study conducted in automatic bath reactor (Table 2.). This is pioneer result, since in the previous studies, fresh mycelium of Aspergillus niger allowed receiving this product as (S) enantiomer. Also the use of Rhizopus arrhizus DSM 1185 (immobilized in polyurethane foams), gave important results, since the bioconversion of phenyl ethanol led, indeed to the racemic mixture of 1-phenylethane-1,2-diol, but it was accompanied by the noticeable tyrosol synthesis, what is reported for the first time.